BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 24157472)

  • 1. Elevated bronchoalveolar lavage eosinophilia correlates with poor outcome after lung transplantation.
    Verleden SE; Ruttens D; Vandermeulen E; van Raemdonck DE; Vanaudenaerde BM; Verleden GM; Vos R
    Transplantation; 2014 Jan; 97(1):83-9. PubMed ID: 24157472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial and Erythrocyte Microvesicles From Bronchoalveolar Lavage Fluid Are Elevated and Associated With Outcome in Chronic Lung Allograft Dysfunction.
    Harms A; Fuehner T; Warnecke G; Haverich A; Gottlieb J; Trummer A
    Transplantation; 2015 Nov; 99(11):2394-400. PubMed ID: 26451527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophilic granulocytes and interleukin-6 level in bronchoalveolar lavage fluid are associated with the development of obliterative bronchiolitis after lung transplantation.
    Scholma J; Slebos DJ; Boezen HM; van den Berg JW; van der Bij W; de Boer WJ; Koëter GH; Timens W; Kauffman HF; Postma DS
    Am J Respir Crit Care Med; 2000 Dec; 162(6):2221-5. PubMed ID: 11112142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bronchiolitis obliterans syndrome and restrictive allograft syndrome: do risk factors differ?
    Verleden SE; Ruttens D; Vandermeulen E; Vaneylen A; Dupont LJ; Van Raemdonck DE; Verleden GM; Vanaudenaerde BM; Vos R
    Transplantation; 2013 May; 95(9):1167-72. PubMed ID: 23425818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential cytokine, chemokine and growth factor expression in phenotypes of chronic lung allograft dysfunction.
    Verleden SE; Ruttens D; Vos R; Vandermeulen E; Moelants E; Mortier A; Van Raemdonck DE; Proost P; Schols D; Verleden GM; Vanaudenaerde BM
    Transplantation; 2015 Jan; 99(1):86-93. PubMed ID: 25050473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction.
    Sato M; Waddell TK; Wagnetz U; Roberts HC; Hwang DM; Haroon A; Wagnetz D; Chaparro C; Singer LG; Hutcheon MA; Keshavjee S
    J Heart Lung Transplant; 2011 Jul; 30(7):735-42. PubMed ID: 21419659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroproliferation in chronic lung allograft dysfunction: Association of mesenchymal cells in bronchoalveolar lavage with phenotypes and survival.
    Combs MP; Xia M; Wheeler DS; Belloli EA; Walker NM; Braeuer RR; Lyu DM; Murray S; Lama VN
    J Heart Lung Transplant; 2020 Aug; 39(8):815-823. PubMed ID: 32360292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of induced sputum and bronchoalveolar lavage in lung transplant recipients.
    Mamessier E; Milhe F; Badier M; Thomas P; Magnan A; Reynaud-Gaubert M
    J Heart Lung Transplant; 2006 May; 25(5):523-32. PubMed ID: 16678030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral Blood Eosinophilia Is Associated with Poor Outcome Post-Lung Transplantation.
    Kaes J; Van der Borght E; Vanstapel A; Van Herck A; Sacreas A; Heigl T; Vanaudenaerde BM; Godinas L; Van Raemdonck DE; Ceulemans LJ; Neyrinck AP; Vos R; Verleden GM; Verleden SE; Group The Leuven Lung Transplant
    Cells; 2020 Nov; 9(11):. PubMed ID: 33233857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma C-reactive protein levels correlate with markers of airway inflammation after lung transplantation: a role for systemic inflammation in bronchiolitis obliterans syndrome?
    Vos R; Vanaudenaerde BM; De Vleeschauwer SI; Van Raemdonck DE; Dupont LJ; Verleden GM
    Transplant Proc; 2009 Mar; 41(2):595-8. PubMed ID: 19328934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating and intrapulmonary C-reactive protein: a predictor of bronchiolitis obliterans syndrome and pulmonary allograft outcome.
    Vos R; Vanaudenaerde BM; De Vleeschauwer SI; Willems-Widyastuti A; Scheers H; Van Raemdonck DE; Dupont LJ; Verleden GM
    J Heart Lung Transplant; 2009 Aug; 28(8):799-807. PubMed ID: 19632576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein in bronchoalveolar lavage fluid is associated with markers of airway inflammation after lung transplantation.
    Vos R; Vanaudenaerde BM; De Vleeschauwer SI; Willems-Widyastuti A; Dupont LJ; Van Raemdonck DE; Verleden GM
    Transplant Proc; 2009 Oct; 41(8):3409-13. PubMed ID: 19857759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bronchoalveolar lavage cytokine profile in a cohort of lung transplant recipients: a predictive role of interleukin-12 with respect to onset of bronchiolitis obliterans syndrome.
    Meloni F; Vitulo P; Cascina A; Oggionni T; Bulgheroni A; Paschetto E; Klersy C; D'Armini AM; Fietta A; Bianco AM; Arbustini E; Viganò M
    J Heart Lung Transplant; 2004 Sep; 23(9):1053-60. PubMed ID: 15454171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alveolar lavage cytological data in lung transplants free of bronchial superinfection. Toulouse Lung Transplantation Group].
    Courtade M; Carré P; Martel S; Caratero A; Caratero C; Thach KS; Léophonte P
    Rev Mal Respir; 1996; 13(4):413-20. PubMed ID: 8927795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary epithelial markers in phenotypes of chronic lung allograft dysfunction.
    Levy L; Moshkelgosha S; Huszti E; Hunter S; Renaud-Picard B; Berra G; Kawashima M; Fernandez-Castillo J; Fuchs E; Dianti M; Ghany R; Keshavjee S; Singer LG; Tikkanen J; Martinu T
    J Heart Lung Transplant; 2023 Aug; 42(8):1152-1160. PubMed ID: 36963446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of bronchoalveolar lavage neutrophilia in stable lung transplant recipients.
    Neurohr C; Huppmann P; Samweber B; Leuschner S; Zimmermann G; Leuchte H; Baumgartner R; Hatz R; Frey L; Ueberfuhr P; Bittmann I; Behr J;
    J Heart Lung Transplant; 2009 May; 28(5):468-74. PubMed ID: 19416775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bile acid aspiration and the development of bronchiolitis obliterans after lung transplantation.
    D'Ovidio F; Mura M; Tsang M; Waddell TK; Hutcheon MA; Singer LG; Hadjiliadis D; Chaparro C; Gutierrez C; Pierre A; Darling G; Liu M; Keshavjee S
    J Thorac Cardiovasc Surg; 2005 May; 129(5):1144-52. PubMed ID: 15867792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exhaled carbon monoxide as a noninvasive marker of airway neutrophilia after lung transplantation.
    Vos R; Cordemans C; Vanaudenaerde BM; De Vleeschauwer SI; Schoonis A; Van Raemdonck DE; Dupont LJ; Verleden GM
    Transplantation; 2009 May; 87(10):1579-83. PubMed ID: 19461497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Airway vascular changes after lung transplant: potential contribution to the pathophysiology of bronchiolitis obliterans syndrome.
    Langenbach SY; Zheng L; McWilliams T; Levvey B; Orsida B; Bailey M; Williams TJ; Snell GI
    J Heart Lung Transplant; 2005 Oct; 24(10):1550-6. PubMed ID: 16210129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BAL neutrophilia in azithromycin-treated lung transplant recipients: Clinical significance.
    Vandermeulen E; Verleden SE; Ruttens D; Moelants E; Mortier A; Somers J; Bellon H; Piloni D; Dupont LJ; Van Raemdonck DE; Proost P; Schols D; Vos R; Verleden GM; Vanaudenaerde BM
    Transpl Immunol; 2015 Sep; 33(1):37-44. PubMed ID: 26168736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.